Article Details

AC Immune acquires AFFiRiS' Specific Active Immunotherapy (SAIT) anti-alpha-synuclein ...

Retrieved on: 2021-07-27 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

AC Immune acquires AFFiRiS' Specific Active Immunotherapy (SAIT) anti-alpha-synuclein .... View article details on hiswai:

Excerpt

"We are delighted that AC Immune, a company with complementary active ... growth companies from Japanese conglomerate SoftBank Group Corp.

Article found on: uk.finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up